Would DMS Imaging (EBR:ALIMG) Be Better Off With Less Debt?
Jun 15
Have your own idea? Try our Stock Screener
Markets has moved to Discover
You can now access Markets by navigating to Discover and selecting Markets.
Belgian (BEL20) Biotech Industry Analysis
UpdatedSep 23, 2024
DataAggregated Company Financials
Companies3
- 7D-0.7%
- 3M13.4%
- 1Y0.9%
- YTD39.6%
Last week, the Biotech industry hasn't moved much but Celyad Oncology is up 7.8% in that time. Furthermore, the industry has been flat for the past year as well. Earnings are forecast to grow by 58% annually.
Industry Valuation and Performance
Has the Belgian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 24 Sep 2024 | €28.9b | €1.5b | -€191,513,251.00 | n/a | -150.7x | 18.9x |
| Thu, 22 Aug 2024 | €28.4b | €1.5b | -€192,372,727.00 | n/a | -147.4x | 18.5x |
| Sat, 20 Jul 2024 | €25.7b | €1.4b | -€310,484,234.70 | n/a | -82.7x | 18.7x |
| Mon, 17 Jun 2024 | €21.5b | €1.4b | -€315,400,919.70 | n/a | -68.1x | 15.4x |
| Wed, 15 May 2024 | €19.7b | €1.4b | -€312,226,573.90 | n/a | -63.1x | 14.3x |
| Fri, 12 Apr 2024 | €21.0b | €1.2b | -€284,315,396.00 | n/a | -73.9x | 17.2x |
| Sun, 10 Mar 2024 | €21.2b | €1.2b | -€301,293,463.20 | n/a | -70.3x | 17.7x |
| Tue, 06 Feb 2024 | €22.0b | €997.2m | -€249,790,257.30 | n/a | -88.2x | 22.1x |
| Thu, 04 Jan 2024 | €20.7b | €1.0b | -€287,495,761.00 | n/a | -72x | 19.9x |
| Sat, 02 Dec 2023 | €24.8b | €1.0b | -€288,131,622.00 | n/a | -86x | 23.8x |
| Mon, 30 Oct 2023 | €26.1b | €882.7m | -€452,807,781.00 | n/a | -57.6x | 29.5x |
| Wed, 27 Sep 2023 | €26.5b | €882.4m | -€452,674,230.00 | n/a | -58.5x | 30x |
| Fri, 25 Aug 2023 | €27.4b | €859.8m | -€457,673,859.00 | n/a | -59.9x | 31.9x |
| Sun, 23 Jul 2023 | €28.8b | €652.9m | -€548,784,162.00 | n/a | -52.5x | 44.1x |
| Tue, 20 Jun 2023 | €20.2b | €664.3m | -€558,115,487.00 | n/a | -36.2x | 30.4x |
| Thu, 18 May 2023 | €21.3b | €669.5m | -€562,362,079.00 | n/a | -37.9x | 31.8x |
| Sat, 15 Apr 2023 | €19.5b | €453.7m | -€726,155,670.00 | n/a | -26.8x | 42.9x |
| Mon, 13 Mar 2023 | €18.1b | €322.3m | -€921,206,032.00 | n/a | -19.6x | 56.2x |
| Wed, 08 Feb 2023 | €19.5b | €313.4m | -€909,808,937.00 | n/a | -21.4x | 62.2x |
| Fri, 06 Jan 2023 | €19.9b | €319.2m | -€922,614,048.00 | n/a | -21.5x | 62.2x |
| Sun, 04 Dec 2022 | €21.6b | €320.2m | -€925,633,551.00 | n/a | -23.4x | 67.5x |
| Tue, 01 Nov 2022 | €22.2b | €338.4m | -€979,984,624.00 | n/a | -22.6x | 65.5x |
| Thu, 29 Sep 2022 | €20.3b | €177.1m | -€1,001,712,475.00 | n/a | -20.3x | 114.8x |
| Sat, 27 Aug 2022 | €21.7b | €169.7m | -€964,640,229.00 | n/a | -22.5x | 128x |
| Mon, 25 Jul 2022 | €19.5b | €395.6m | -€637,842,846.00 | n/a | -30.5x | 49.2x |
| Wed, 22 Jun 2022 | €18.6b | €383.2m | -€618,558,720.00 | n/a | -30.1x | 48.6x |
| Fri, 20 May 2022 | €16.5b | €382.0m | -€616,743,007.00 | n/a | -26.7x | 43.2x |
| Sun, 17 Apr 2022 | €16.5b | €509.4m | -€431,115,156.00 | n/a | -38.2x | 32.3x |
| Tue, 15 Mar 2022 | €13.4b | €511.3m | -€415,504,877.00 | n/a | -32.1x | 26.1x |
| Thu, 10 Feb 2022 | €13.6b | €464.1m | -€398,651,021.00 | n/a | -34x | 29.2x |
| Sat, 08 Jan 2022 | €14.9b | €468.0m | -€401,617,309.00 | n/a | -37.1x | 31.8x |
| Mon, 06 Dec 2021 | €13.4b | €470.1m | -€403,260,793.00 | n/a | -33.2x | 28.5x |
| Wed, 03 Nov 2021 | €14.3b | €458.2m | -€392,245,589.00 | n/a | -36.6x | 31.3x |
| Fri, 01 Oct 2021 | €13.6b | €464.6m | -€361,654,835.00 | n/a | -37.6x | 29.3x |
Price to Earnings Ratio
-37.6x
Current Industry PE
- There are only 3 companies in the Belgian Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Revenues for these companies have grown 49% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Belgian Healthcare industry?
| BE Market | -1.14% | |
| Healthcare | -0.93% | |
| Biotech | -0.72% | |
| Biotech | -0.72% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CYAD Celyad Oncology | €0.26 | 6.5% +€642.1k | -63.4% | PS147x |